Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Milano

Showing results (251-260 of 347) with videos related to

Pageof 35
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 13, 2006
EGFR expression in colon cancer: a break in the cloudsM-C Etienne-Grimaldi, A Cayre, F Penault-Llorca, et al.
British Journal of Cancer|March 1, 1991
Dose reduction without loss of efficacy for 5-fluorouracil and cisplatin combined with folinic acid. In vitro study on human head and neck carcinoma cell linesM C Etienne, S Bernard, J L Fischel, et al.
Anales De Pediatria (Barcelona, Spain : 2003)|March 17, 2012
[Black hairy tongue in an infant]J M González Gómez, M J Peláez Cantero, J L de la Mota Ybancos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1992
Influence of sex and age on fluorouracil clearanceG Milano, M C Etienne, E Cassuto-Viguier, et al.
Journal of the National Cancer Institute|June 16, 1993
Marked fluctuations in drug plasma concentrations caused by use of portable pumps for fluorouracil continuous infusionM C Etienne, G Milano, J L Lagrange, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 26, 2003
Impact of platinum complexes on dihydropyrimidine dehydrogenase activity in 5-fluorouracil-treated patientsN Magné, X Pivot, M C Etienne-Grimaldi, et al.
Journal of Clinical Pharmacy and Therapeutics|November 25, 2003
Fas/FasL expression in tumor biopsies: a prognostic response factor to fluoropyrimidines?K Bezulier, F Fina, M Roussel, et al.
Journal of the National Cancer Institute|June 20, 1990
Phase I trial of 5-day continuous venous infusion of oxaliplatin at circadian rhythm-modulated rate compared with constant rateJ P Caussanel, F Lévi, S Brienza, et al.
European Journal of Cancer (Oxford, England : 1990)|March 26, 2003
Dihydropyrimidine dehydrogenase circadian rhythm in mouse liver: comparison between enzyme activity and gene expressionB Porsin, J-L Formento, E Filipski, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 25, 2003
Phase I and pharmacokinetic study of the association of capecitabine-cisplatin in head and neck cancer patientsX Pivot, E Chamorey, E Guardiola, et al.
Pageof 35

Showing results (251-260 of 347) with videos related to

Sort By:
Pageof 35
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 13, 2006
EGFR expression in colon cancer: a break in the cloudsM-C Etienne-Grimaldi, A Cayre, F Penault-Llorca, et al.
British Journal of Cancer|March 1, 1991
Dose reduction without loss of efficacy for 5-fluorouracil and cisplatin combined with folinic acid. In vitro study on human head and neck carcinoma cell linesM C Etienne, S Bernard, J L Fischel, et al.
Anales De Pediatria (Barcelona, Spain : 2003)|March 17, 2012
[Black hairy tongue in an infant]J M González Gómez, M J Peláez Cantero, J L de la Mota Ybancos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1992
Influence of sex and age on fluorouracil clearanceG Milano, M C Etienne, E Cassuto-Viguier, et al.
Journal of the National Cancer Institute|June 16, 1993
Marked fluctuations in drug plasma concentrations caused by use of portable pumps for fluorouracil continuous infusionM C Etienne, G Milano, J L Lagrange, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 26, 2003
Impact of platinum complexes on dihydropyrimidine dehydrogenase activity in 5-fluorouracil-treated patientsN Magné, X Pivot, M C Etienne-Grimaldi, et al.
Journal of Clinical Pharmacy and Therapeutics|November 25, 2003
Fas/FasL expression in tumor biopsies: a prognostic response factor to fluoropyrimidines?K Bezulier, F Fina, M Roussel, et al.
Journal of the National Cancer Institute|June 20, 1990
Phase I trial of 5-day continuous venous infusion of oxaliplatin at circadian rhythm-modulated rate compared with constant rateJ P Caussanel, F Lévi, S Brienza, et al.
European Journal of Cancer (Oxford, England : 1990)|March 26, 2003
Dihydropyrimidine dehydrogenase circadian rhythm in mouse liver: comparison between enzyme activity and gene expressionB Porsin, J-L Formento, E Filipski, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 25, 2003
Phase I and pharmacokinetic study of the association of capecitabine-cisplatin in head and neck cancer patientsX Pivot, E Chamorey, E Guardiola, et al.
Pageof 35